Derek Raghavan, M.D., Ph.D.
| Appointed: |
2004 |
| Gender: |
Male |
| Languages: |
English |
Taussig Cancer Institute
Solid Tumor Oncology
Urology
Translational Hematology and Oncology Research
Professional Highlights
- M. Frank and Margaret Domiter Rudy Institute (Distinguished) Chair in Translational Cancer Research
- Former Chair, National Cancer Institute Cancer Clinical Investigations Review Committee
- Former Chair, Veterans Administration Merit Review Board in Oncology
- Former member, FDA Oncology Drug Advisory Committee
- Member, National Cancer Institute Clinical Oncology Grants Review Committee
- Fellow, American Association for the Advancement of Science
Education & Fellowships
| Medical School: | University of Sydney-Faculty of Medicine, Sydney, Australia, Australia |
|
| Internship: | Royal Prince Alfred Hospital, Surgery, Australia |
| Residency: | Royal Prince Alfred Hospital, Internal Medicine, Australia |
| Fellowship: | Royal Marsden Hospital, Medical Oncology, Sutton, Surrey, England |
| Fellowship: | Royal Prince Alfred Hospital, Medical Oncology, Australia |
| Other Education: | (Doctorate) University of London, London, United Kingdom |
| Other Education: | (Research Fellowship) University of Minnesota Hospital and Clinic, Minneapolis, MN |
Certifications
Royal Australasian College of Physicians - Internal Medicine
Royal Australasian College of Physicians - Medical Oncology
Specialty Interests
Bladder Cancer, prostate cancer and prostatic disease, Prostate Cancer, Prostate Disease, Lung Cancer, Testis Cancer.
Innovations & Patents
- Extensive phase I-II testing of new anticancer drugs
- Clinical trial of circulating tumor cell assay led to FDA approval for use as prognostic tool for prostate cancer
- CCF Innovations Award for research on pH changes in tumor cells (with Dan Lindner, MD, PhD)
Awards & Honors
- Fellow, American College of Physicians
- Fellow, Royal Australasian College of Physicians
- Fellow, American Academy for the Advancement of Science
- Best Doctors of America
- America's Top Doctors
- America's Top Doctors for Cancer
- Cleveland magazine
- Northeast Ohio
- Who's Who in the World
- Who's Who in America
- Who's Who in Science and Engineering
- Who's Who in Cancer
- M. Frank and Margaret Domiter Rudy Institute (Distinguished) Chair in Translational Cancer Research
- Frank S. Moran Award for Leadership in Cancer Research, University of Michigan
Professional Memberships
- American Society of Clinical Oncology
- American Association for Cancer Research
- Society of Urologic Oncology
- American College of Physicians
- Southwest Oncology Group
- Royal Australasian College of Physicians
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Raghavan has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Raghavan receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Gerson Lehrman Group
- ISIS Pharmaceuticals, Inc.
Equity. Dr. Raghavan owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
